It is important to distinguish between documented adverse effects and patient-reported symptoms that may or may not be directly attributable to the medication
This guide examines what Epithalon is and how it works at the cellular level, documented anti-aging and longevity benefits from research, telomerase activation and telomere lengthening effects, sleep and circadian rhythm improvements, immune system enhancement, complete dosing protocols for different goals, side effects and safety profile, and comparing Epithalon to other longevity peptides
49.99 You save 49.99 You save UK research-grade semaglutide 10mg
In TRIUMPH-1, people taking retatrutide 12mg lost an average of 28.3% of their starting body weight at 80 weeks
TRANSCEND-T2D-1 (Type 2 Diabetes): Results released in March 2026 found that participants with type 2 diabetes who received the 12 mg dose lost an average of 16.8% of their body weight after 40 weeks